The Effect of Inflammatory Reactions on Antibody Unresponsiveness to Hepatitis B Vaccine in Hemodialysis Patients

Dede Sit; Ali Kadiroglu; Hasan Kayabasi; Zulfukar yilmaz; Mehmet Yilmaz

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

The Effect of Inflammatory Reactions on Antibody Unresponsiveness to Hepatitis B Vaccine in Hemodialysis Patients

Author(s):

Dede Sit^1,*,

Ali Kemal Kadiroglu²,

Hasan Kayabasi²,

Zulfukar yilmaz²,

Mehmet Emin Yilmaz³

1Department of Nephrology, Faculty of Medicine ,Dicle University, drdede75@hotmail.com, Turkey

2Department of Internal Medicine, Faculty of Medicine, Dicle University, Turkey

3Diyarbakir, Turkey

Hepatitis Monthly:Vol. 7, issue 1; 15-19

Published online:Mar 31, 2007

Article type:Research Article

Received:Feb 15, 2006

Accepted:Oct 10, 2006

How to Cite:Sit D, Kadiroglu A K, Kayabasi H, yilmaz Z, Yilmaz M E. The Effect of Inflammatory Reactions on Antibody Unresponsiveness to Hepatitis B Vaccine in Hemodialysis Patients.Hepat Mon.2007;7(1):15-19.

Abstract

Background and Aims: In this study, the effect of infections and inflammation developed during hepatitis B vaccination program on antibody response in hemodialysis (HD) patients was evaluated.

Methods: In total, 94 patients who had hepatitis B surface antigen (HBsAg) (-), antibody to hepatitis B surface (antiHBs) (-), antibody against hepatitis B core immunoglobulin G (antiHBcIgG) (-) (Group A) and who were previously vaccinated but having antibody titer levels lower than 10 mIU/mL (Group B), on maintenance HD program were included in this study. In group A, 40 |μ|g intramuscular vaccine on 0, 1, 2 and 6 months and in group B, 40 μ|g of intramuscular booster dose vaccine were administered. Antibody titer of 10 mIU/mL was considered as positive. Group A was then divided into two subgroups with respect to antibody response (Group A1 and Group A2).

Results: Eighty-one patients completed the study (Group A; n=64, mean age=42.3±11.4 years; Group B: n=17, mean age=53.6±10.6 years). In Group A, antibody response was positive in 82.8% (Group A1), negative in 17.2% (Group A2) and it was positive in 100% of Group B. Inflammatory parameters, nutritional and demographic features were found similarly in all groups. Throughout the study, infections developed most frequently in Group A.

Conclusions: We concluded that acute infections and inflammations developed in patients vaccinated according to vaccination schedule recommended for HBV prophylaxis during HD treatment does not affect antibody response and acute phase reactants are not indicators for negative antibody response.

Keywords

Full Text

Full text is available in PDF

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 5 days ago
Scopus by Title: 3
Last Update: 5 days ago
Scopus by Title (Ref): 3
Last Update: 5 days ago
CrossRef: 0
Last Update: 5 days ago

Metrics

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Dede Sit:[PubMed][Scholar]
Ali Kadiroglu:[PubMed][Scholar]
Hasan Kayabasi:[PubMed][Scholar]
Zulfukar yilmaz:[PubMed][Scholar]
Mehmet Yilmaz:[PubMed][Scholar]

Official Journal of Research Center for Gastroenterology and Liver Diseases

Outlines

The Effect of Inflammatory Reactions on Antibody Unresponsiveness to Hepatitis B Vaccine in Hemodialysis Patients

Abstract

Full Text

Last Update: 5 days ago

Last Update: 5 days ago

Last Update: 5 days ago

Last Update: 5 days ago